Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs neostigmine for postoperative recovery and pulmonary complications after total hip arthroplasty in elderly patients
ChiCTR2000039341Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of Sugammadex in femoral fracture (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: time to extubation. Started Oct 2020; status: recruiting.
02
Drugs
Sugammadex
03
Conditions
femoral fracture
Beyond the preview
Go deeper on ChiCTR2000039341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039341.